文摘
Cisplatin nanocapsules represent a lipid formulation of the anticancer drug cis-diamminedichloroplatinum(II) (cisplatin) characterized by an unprecedented cisplatin-to-lipid ratio and exhibiting stronglyimproved cytotoxicity against tumor cells in vitro as compared to the free drug (Burger, K. N. J., et al. Nat.Med. 2002, 8, 81-84). Cisplatin nanocapsules are prepared by the repeated freezing and thawing of anequimolar dispersion of phosphatidylserine (PS) and phosphatidylcholine (PC) in a concentrated aqueoussolution of cisplatin. Here, the molecular architecture of these novel nanostructures was elucidated bysolid-state NMR techniques. 15N NMR and 2H NMR spectra of nanocapsules containing 15N- and 2H-labeledcisplatin, respectively, demonstrated that the core of the nanocapsules consists of solid cisplatin devoid offree water. Magic-angle spinning 15N NMR showed that ~90% of the cisplatin in the core is present as thedichloro species. The remaining 10% was accounted for by a newly discovered dinuclear Pt compoundthat was identified as the positively charged chloride-bridged dimer of cisplatin. NMR techniques sensitiveto lipid organization, 31P NMR and 2H NMR, revealed that the cisplatin core is coated by phospholipids ina bilayer configuration and that the interaction between solid core and bilayer coat exerts a strong orderingeffect on the phospholipid molecules. Compared to phospholipids in liposomal membranes, the motion ofthe phospholipid headgroups is restricted and the ordering of the acyl chains is increased, particularly inPS. The implications of these findings for the structural organization, the mechanism of formation, and themode of action of cisplatin nanocapsules are discussed.